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Regular monitoring of mosquito vector populations is an integral component of most vector control programmes. Contemporary
data on mosquito species composition, infection status, and resistance to insecticides are a prerequisite for eﬀective intervention.
For this purpose we, with funding from the Innovative Vector Control Consortium (IVCC), have developed a suite of high-
throughput assays based on a single “closed-tube” platform that collectively comprise the “Vector Population Monitoring Tool”
(VPMT). The VPMT can be used to screenmosquito disease vector populations for a number of traits including Anopheles gambiae
s.l. and Anopheles funestus species identification, detection of infection with Plasmodium parasites, and identification of insecticide
resistance mechanisms. In this paper we focus on the Anopheles-specific assays that comprise the VPMT and include details of a
new assay for resistance to dieldrin Rdl detection. The application of these tools, general and specific guidelines on their use based
on field testing in Africa, and plans for further development are discussed.
1. Introduction
A key component of most malaria control strategies is
eﬀective control of the mosquito vector. Indeed the World
Health Organization supports vector control as the most
generally eﬀective measure to prevent malaria transmission
and promotes a strategic approach to vector control known
as Integrated Vector Management (IVM) [1]. IVM is defined
as “a rational decision-making process for the optimal use
of resources in the management of vector populations, so as
to reduce or interrupt transmission of vector-borne diseases”
[1]. An essential part of IVM is the gathering of contem-
porary information on vector populations. Data, such as
which mosquito species occur in the local population, their
infection status, and whether they are resistant to insecticides
are essential for eﬀective intervention strategies. This type
of monitoring requires high-throughput sensitive diagnostic
assays, and a large number of diﬀerent methods have been
described for this purpose. In many cases, these methods
have garnered wide-spread acceptance and are now consid-
ered “gold standards”; however, in other cases, potentially
serious deficiencies have been described [2, 3]. In addition,
previous methods have been based on a multitude of plat-
forms including, but not limited to, allele-specific PCR (AS-
PCR), PCR-RFLP, Enzyme-linked Immunosorbent Assay
(ELISA), Sequence Specific Oligonucleotide Probe-Enzyme-
Linked Immunosorbent Assay (SSOP-ELISA), PCR-Dot Blot
and Heated Oligonucleotide Ligation Assay (HOLA), and
this complicates their integrated use [4].
To address this, the Technology Development Group of
the Innovative Vector Control Consortium has developed
simple, high-throughput diagnostic assays to gather data
on the status of mosquito vector populations [5]. The
Anopheles-specific assays that comprise the “Vector Popula-
tion Monitoring Tool” (VPMT) consist of a suite of high-
throughput assays based on a single platform that can be used
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to screen vector populations for a number of traits. These
include (1) Anopheles gambiae s.l. and Anopheles funestus
species identification, (2) detection of infection with Plas-
modium parasites, and (3) detection of insecticide resistance
mechanisms [4, 6–10]. The latter currently consists of three
mechanism-specific assays and includes (1) detection of
knock-down resistance (kdr) mutations, (2) detection of
insensitive acetylcholinesterase (iAChE), and (3) detection
of resistance to dieldrin (Rdl). The assays that constitute
the VPMT have been designed to be high throughput and
require very small amounts of starting material (DNA) that
can be extracted from mosquitoes that have been stored in
a wide variety of ways (e.g., in ethanol, isopropanol, dried,
and frozen). This ensures that they can be used for assaying
field-collected mosquitoes without the need for a cold chain
to preserve the specimens.
The assays are based on TaqMan SNP genotyping, a
PCRmethod employing oligonucleotide probes that are dual
labelled with a fluorescent reporter dye and a quencher
molecule. As shown in Figure 1, amplification of the probe-
specific product causes cleavage of the probe, generating
an increase in reporter fluorescence as the reporter dye is
released away from the quencher. By using diﬀerent reporter
dyes, cleavage of allele-specific probes can be detected in a
single PCR [11]. The “closed-tube” nature of the TaqMan
platform means that there is no requirement for post-PCR
processing and consequently assays are simple to perform
and rapid to run.
In this paper we detail the assays that comprise the
Anopheles-specific VPMT and provide advice on their use
based on field testing of assays in Africa by ourselves and
others. Finally, we discuss the application of these tools, the
advantages and disadvantages of the platform on which they
are based, and future development.
2. Species Identification
Identification of the species in the Anopheles gambiae sensu
lato (s.l.) complex and the Anopheles funestus group is an
important part of vector control programmes as both groups
comprise species with diﬀerent eﬃciencies as vectors and the
distribution of diﬀerent members often overlap.
3. An. gambiae S.L. Species Complex
The An. gambiae sensu lato (s.l.) species complex comprises
seven species of mosquitoes that are morphologically indis-
tinguishable but diﬀer in their behaviour and ability to vector
malaria. Anopheles gambiae sensu stricto s.s. and Anopheles
arabiensis are the two principal vectors, whilst two other
membersAnopheles melas, andAnopheles merus are both salt-
water breeding and consequently only important vectors in
coastal regions [12, 13]. Of the remaining members, Anophe-
les quadriannulatus species A and Anopheles quadriannulatus
species B are considered to be zoophilic non-malaria vectors
[14, 15], while Anopheles bwambae is restricted to a region
close to the Buranga hot springs in Uganda [16].
Two alternative TaqMan assays for identification of
members of this species complex have been developed as part
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Figure 1: TaqMan SNP genotyping. The TaqMan assay is a
PCR method employing oligonucleotide probes that are dual
labelled with a fluorescent reporter dye and a quencher molecule.
Amplification of the probe-specific product causes cleavage of
the probe, generating an increase in reporter fluorescence as the
reporter dye is released away from the quencher.
of the VPMT. The first [9] uses two probes to distinguish
between the main malaria vectors An. gambiae s.s. and An.
arabiensis as one group (detected by a probe labelled with
the fluorophore FAM) and An. quadriannulatus, An. melas
or An. merus as a second group (detected by a probe labelled
with the fluorophore VIC). This assay can be used alone to
discriminate vector from nonvector (in regions where An.
merus/melas/bwambae are not present) or in combination
with an existing TaqMan assay [17] to further distinguish
An. arabiensis from An. gambiae s.s.. The performance of
this assay was compared with the “gold standard” AS-PCR
method in a blind species identification trial of over 450
specimens collected from 13 countries in Sub-Saharan Africa
[9]. The results showed that the TaqMan assay is comparable
in specificity to standard PCR but is more sensitive, due to a
lower detection threshold, and this results in a significantly
lower rate of “failed reactions” (samples that cannot be
identified due to low or no amplification). An advantage of
this assay is its compatibility with real-time PCR machines
that have two detection channels that are generally lower in
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cost than machines with three or more detection channels.
A disadvantage of this assay is that, when used alone, it
cannot discriminate between the two main vector species,
An. gambiae s.s. and An. arabiensis. Therefore, a second assay
[8] that overcomes this limitation was developed that uses
three probes (labelled with Cy5, VIC, and FAM, resp.) to
distinguish between An. arabiensis, An. gambiae s.s., and
An. quadriannulatus/merus/melas/bwambae as a group. This
assay requires a real-time PCRmachine that has at least three
detection channels. A genotyping trial with the sample set
described above showed the new multiplex TaqMan assay
to have a specificity and sensitivity comparable to the 2-
plex TaqMan assay [8]. A disadvantage of this assay is its
limited use in regions where An. merus and An. melas are
important local vector species and occur in sympatry with
An. quadriannulatus. For this reason a future priority is to
develop an assay that is able to discriminate these three
species for application in such regions.
An. gambiae s.s. is currently considered to be undergoing
speciation into two molecular forms (M and S). However
recent studies of the genetic divergence of the two forms
have indicated that this process may be more advanced than
previously thought [18, 19]. The current TaqMan assays do
not discriminate betweenmolecular forms ofAn. gambiae s.s.
and a high-throughput assay, for this purpose is, therefore, an
important future objective.
4. An. funestus Species Complex
The Anopheles funestus group consists of five subgroups (1)
Anopheles funestus, (2) Anopheles rivulorum, (3) Anopheles
minimus, (4) Anopheles aconitus, and (5) Anopheles culicifa-
cies [20–22]. The African mosquito species An. funestus s.s.,
Anopheles parensis, andAnopheles vaneedeni, belonging to the
An. funestus subgroup, and Anopheles leesoni and Anopheles
rivulorum, belonging to the An. minimus and An. rivulorum
subgroups, respectively, are either morphologically identical
or very similar and may occur in sympatry over large parts of
their distribution [22]. The vectorial capacity, biology, and
behaviour of these species diﬀer. Anopheles funestus s.s. is
one of the most important African vectors of malaria [21]
as a result of its anthropophilic and endophilic behaviour.
The other species are predominantly zoophilic and exophilic
[20, 21] and are thought to have limited, or no, importance
as malaria vectors, although An. vaneedeni has been shown
to be susceptible to Plasmodium infection under laboratory
conditions [23, 24] and An. rivulorum has been found
infected with the Plasmodium parasite at one locality in
Tanzania [25].
A multiplex TaqMan assay was, therefore, developed
that detects and discriminates An. parensis, An. leesoni, An.
vaneedeni, An. rivulorum, and An. funestus s.s [10]. The assay
uses five probes labelled at the 5′ end with VIC for An.
parensis detection, 6FAM for An. leesoni detection, Cy5 for
An. rivulorum detection, ROX for An. funestus s.s. detection,
and Quasar 705 for An. vaneedeni detection. These five
fluorophores have distinct emission and excitation spectra
allowing their independent detection in a single reaction. In a
blind trial, the TaqMan assay proved to be at least as sensitive
and specific as the “gold standard” AS-PCR approach [10].
A disadvantage of the TaqMan assay is the requirement for a
five-channel real-time PCR machine however, it may not be
necessary for end users to test for all species. For example, it
may not be necessary to test for An. vaneedeni in many Sub-
Saharan countries as its distribution is limited to a localised
region in Northern South Africa [20, 21].
5. Plasmodium Infection
An essential component of malaria vector control and
monitoring programmes is the sensitive detection of the
presence of the four human-specific Plasmodium species
(Plasmodium falciparum, Plasmodium vivax, Plasmodium
ovale and Plasmodium malariae) in the mosquito host. The
infection status of a mosquito is usually assessed by the
presence/absence of Plasmodium sporozoites in the salivary
glands.
A TaqMan assay was developed that detects all four
malaria-causing Plasmodium species and discriminates P.
falciparum from P. vivax, P. ovale and P. malariae [6].
The assay uses two probes, the first labelled with FAM
detects P. falciparum and the second, labelled with VIC
detects P. vivax/P. ovale/P. malariae. Unlike the widely used
circumsporozoite protein-ELISA method the TaqMan assay
targets species specific sequence variation in the small
subunit ribosomal RNA gene and is therefore, not stage
specific. This assay will therefore detect stages of Plasmodium
in the blood meal/gut of the mosquito, and to ensure that
only sporozoites within the salivary glands are detected,
DNA should be extracted from head thorax only and the
abdomen removed prior to extraction. The sensitivity and
the specificity of the new assay was compared to three
alternative PCR approaches and to microscopic dissection of
salivary glands in a blind trial of single insect samples that
included artificially infected Anopheles stephensi mosquitoes
and more than 450 field-collected specimens that had been
stored either on silica gel or in ethanol or isopropanol. Tests
of analytical sensitivity and the results of the blind trial
showed the TaqMan assay to be the most sensitive of the
four methods followed by the “gold standard” nested PCR
approach and the results generated using these two methods
were in good concordance [6]. The TaqMan method was not
inhibited by any of the mosquito storage methods.
6. Resistance to Insecticides
Current vector control strategies rely heavily on the use
of insecticides, most commonly employed as insecticide-
treated nets (ITNs) and indoor residual spraying (IRS).
Unfortunately, their intensive use has led to the development
of resistance and this has the potential to seriously compro-
mise malaria control eﬀorts [26, 27]. Sensitive detection of
resistance is a prerequisite for resistance management strate-
gies aimed at prolonging insecticide life while maintaining
suﬃcient insect control. Bioassay assessment of mosquito
vector populations for resistance is an essential component
4 Malaria Research and Treatment
Table 1: Mosquito and Plasmodium specimens suitable for use as controls in VPMT assays that are available from the Malaria Research and
Reference Reagent Resource Centre (MR4) http://www.mr4.org/.
Applicable TaqMan assay MR4 reference No. Species/genotype Further details
Species ID MRA-495 An. arabiensis Genomic DNA from KGB (MRA-339)
Species ID MRA-142 An. gambiae Genomic DNA from An. gambiae, G3 strain
Species ID MRA-761 An. quadriannulatus from South Africa
Plasmodium infection MRA-102G Plasmodium falciparum Genomic DNA from P. falciparum 3D7
Plasmodium infection MRA-341G Plasmodium vivax Genomic DNA from P. vivax ONG
Kdr assay MRA-762 An. gambiae/homozygous wild type
KISUMU strain, considered the insecticide
susceptible standard
Kdr assay MRA334 An. gambiae/homozygous for L1014S
RSP strain, expresses the L1014S kdr
mechanism
Rdl assay MRA-762 An. gambiae/homozygous wild type
KISUMU strain, considered the insecticide
susceptible standard
Rdl assay MRA-495 An. arabiensis/homozygous wild type Genomic DNA from KGB (MRA-339)
Rdl assay MRA-116 An. gambiae/homozygous for A296G
P+DLRC+R+ strain, dieldrin resistant due to
Rdl mutation (Ala296Gly)
Rdl assay MRA764 An. arabiensis/homozygous for A296S
SENN strain, dieldrin resistant due to Rdl
mutation (Ala296Ser)
of monitoring programmes as it can detect moderate-to-high
resistance phenotypes regardless of the underlying resistance
mechanism(s). However, the methodology involved can be
time consuming, requires live insects in good condition, and
often cannot detect resistance at a low frequency. In contrast,
mechanism-specific high-throughput diagnostic assays are
both more rapid and can detect resistance earlier.
6.1. Detection of Knock down Resistance (kdr). Knockdown
resistance (kdr) is a well-characterized mechanism of resis-
tance to DDT and pyrethroid insecticides in many insect
species and is caused by point mutation of the target
site, the para-type sodium channel. In pyrethroid resistant
An. gambiae, two amino acid substitutions at the same
position (L1014F and L1014S) have been reported, initially
in An. gambiae s.s. [28, 29] and more recently in Anopheles
arabiensis [30, 31]. Recently, individuals heterozygous for
both the F1014 and S1014 alleles have been reported [3, 32].
Two assays have been developed for the detection of the
L1014F or L1014S mutations [4]. Both kdr assays use two
probes, the first specific for the wild-type allele is labelled
with VIC and the second specific for the mutant allele (F1014
and S1014), is labelled with FAM. In both assays a substantial
increase in VIC fluorescence indicates a homozygous wild-
type, a substantial increase in FAM fluorescence indicates
a homozygous mutant and a usually intermediate increase
in both signals indicates a heterozygote (see example in
Figure 2). Individuals homozygous for the L1014S mutation
display no increase in VIC or FAM fluorescence in the
L1014F assay, and vice versa. The sensitivity and specificity of
the TaqMan assays was compared to four previously reported
techniques for kdr detection, Allele Specific Polymerase
Chain Reaction (AS-PCR), Heated Oligonucleotide Ligation
Assay (HOLA), Sequence Specific Oligonucleotide Probe-
Enzyme-Linked Immunosorbent Assay (SSOP-ELISA) and
PCR-Dot Blot in a blind genotyping trial of 96 single insect
samples that included a variety of kdr genotypes and African
Anopheline species. The results demonstrated that the real-
time TaqMan assays were both the most sensitive (with the
lowest number of failed reactions) and the most specific
(with the lowest number of incorrect scores) [4].
6.2. Detection of Insensitive Acetylcholinesterase (iAChE).
Resistance to organophosphate and carbamate insecticides in
Anopheles gambiae can result from insensitivity of the target
site enzyme, acetylcholinesterase [33]. Resistance results
from a single nucleotide substitution in the ace-1 gene
encoding the enzyme, conferring a Glycine to Serine (G119S)
amino acid substitution (termed ace-1R) in the oxyanion
hole of the enzyme. A TaqMan assay [7] was developed for
sensitive detection of this mutation that like the kdr assays
uses two probes, the first labelled with VIC is specific for the
wild-type (G119) allele, and the second labelled with FAM
is specific for the mutant allele (S119). The TaqMan assay
was compared to the existing standard PCR-RFLP method
to genotype over 280 samples and proved to be both more
sensitive and specific [7].
6.3. Detection of Resistance to Dieldrin (Rdl). In many insect
species, resistance to cyclodiene insecticides is caused by
amino acid substitutions at a single residue within the
M2 transmembrane region of the γ-aminobutyric acid
(GABA) receptor subunit termed Rdl (resistance to dieldrin)
[34]. These mutations have also been shown to confer
low levels of cross-resistance to fipronil, a phenylpyrazole
insecticide with a similar mode of action to cyclodienes. Two
alternative mutations have been reported in An. gambiae
sensu lato (s.l.), A296G in An. gambiae s.s. and A296S in
An. arabiensis [35]. Two TaqMan assays, one for each of
the two alternative mutations, are reported here for the
first time. The A296G assay uses two primers, GlyRdlF
(5′ -TCATATCGTGGGTATCATTTTGGCTAAAT-3′) and
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Figure 2: Real-time TaqMan detection of the L1014F kdr mutation. S: wild-type allele (L1014), R: resistant allele (L1014F).
Table 2: Approximate cost of each of the VPMT assays per
mosquito specimen analysed. In each case costings were calculated
in US$ by using retail prices from US websites. These prices do
not include promotional or negotiated discounts or the cost of
delivery. All primer/probe/PCR MasterMix costs are from ordering
at the largest available scale. Cost calculations include all the plastics
required to set up the reactions. For the cost of the kdr and Rdl
assays, this is the combined cost of running two assays (i.e., A296G
+ A296S).
Assay Cost in US$
An. gambiae species ID (2 plex assay) 0.75
An. gambiae species ID (3 plex assay) 1
An. funestus species ID 0.95
Plasmodium detection assay 0.75
Kdr assay 1.5
iAChE assay 0.75
Rdl assay 1.5
GlyRdlR (5′ -CGACATCAGTGTTGTCATTGTCAAG-3′)
and two probes, WT1 (5′ -ACGTGTTGCATTAGG-3′)
specific for the wild-type allele labelled with VIC and Gly (5′
-ACGTGTTGGATTAGG-3′), specific for the mutant allele
(G296) labelled with FAM. The A296S assay uses primers
SerRdlF (5′ -TCATATCGTGGGTATCATTTTGGCTAAAT-
3′) and SerRdlR (5′ -TCGTTGACGACATCAGTGTTGT-3′)
and two probes, WT2 (5′ -TTACACCTAATGCAACACG-
3′) specific for the wild-type allele labelled with VIC and Ser
(5′ -CACCTAATGAAACACG-3′), specific for the mutant
allele (S296) labelled with FAM. All probes also have a 3′
nonfluorescent quencher and a minor groove binder at the
3′ end. The minor groove binder provides more accurate
allelic discrimination by increasing the T M betweenmatched
and mismatched probes [36]. PCR reaction conditions are
as described for the kdr assay [4] except for temperature
cycling conditions for the A296G assay which were 10
minutes at 95◦C followed by 40 cycles of 95◦C for 10
seconds and 62◦C for 45 seconds. In either assay a substantial
increase in VIC fluorescence indicates a homozygous wild-
type, a substantial increase in FAM fluorescence indicates
a homozygous mutant, and a usually intermediate increase
in both signals indicates a heterozygote (Figure 3). The
sensitivity and specificity of the TaqMan assays was examined
using serial dilutions of mosquito DNA extracted from
individuals of the An. gambiae P+DLRC+R+ (homozygous
for A296G) and Kisumu strains (wild type), An. arabiensis
SENN (homozygous for A296S), and KGB strains (wild type)
and An gambiae s.l. samples from Ghana and Cameroon that
were heterozygous for A296G or A296S by sequencing. For
this DNA preparations were diluted to 20 ng/ul then serially
diluted down to a 1 in 1×104 dilution. In this small scale
trial of 96 samples, the assay correctly identified all possible
genotypes, and the limit of detection for both the A296G and
A296S TaqMan assays was a 1 in 10,000 dilution representing
2pg DNA.
7. Feedback from Field Testing
Field testing of the VPMT by ourselves and others has taken
place in Malawi and South Africa, and VPMT protocols
are now being used routinely to support interventions in
Equatorial Guinea and southern Africa and for other studies
[37–40]. Feedback from end users has enabled us to develop
additional guidelines and advice. General advice applicable
to the use of all the VPMT protocols is as follow. (1) Include
controls in assay runs. We recommend that these include
one or more no-template controls and in the case of the
An. gambiae s.l. species ID and Plasmodium infection assays
a positive control for each probe (e.g., An. gambiae s.s, An.
arabiensis and An. quadriannulatus for the 3-plex species ID
assay and P. falciparum and P. vivax for the Plasmodium
assay). In the case of the kdr, iAChE and Rdl assays a
control template for each genotype should be included
(e.g., when running the L1014F assay include a L1014F
homozygous sample, a wild-type homozygous sample, and a
L1014F heterozygous sample). We have found that including
these controls greatly facilitates the interpretation of results
and generally speeds up the scoring of unknown samples.
In this regard Table 1 details relevant control genotypes
currently available from the Malaria Research and Reference
Reagent Resource Center (MR4), http://www.mr4.org/. (2)
We recommend making aliquots of all reagents to avoid
repeated freeze-thawing. This is especially important for
fluorescently labelled probes which should also be stored
out of the light to prevent UV degradation. If probes or
reagents need to be transported a thermos flask full of ice
and a small amount of salt will keep them cold for up to 24
hours. (3) We have found that the “auto-scale” function of
the software that accompanies most real-time PCRmachines
should be used with caution as this can artificially elevate
the fluorescent trace resulting in misscoring. (4) If further
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Figure 3: Real-time TaqMan detection of the Rdl mutation in Anopheles gambiae and Anopheles arabiensis. (a) and (b) Detection of the
A296S mutation. (c) and (d) Detection of the A296G mutation.
assay optimisation is required the annealing temperature,
the concentration of probes in the reaction and number of
temperature cycles are good parameters to alter in attempts
to enhance sensitivity or reduce nonspecific signals. (5) We
have found the TaqMan protocols to be largely unaﬀected
by variation in DNA extraction methodology and a range of
popular extraction methods can be used to good eﬀect [4]
the exception to this rule is the Plasmodium assay (discussed
below).
7.1. Specific Advice on the An. gambiae S.l. Species Complex
Identification Assay. The 3-plex species identification assay
was initially run on a Corbett rotorgene PCR machine with
an annealing/extension time of 60◦C. At this temperature the
probes Aa and Aq (Cy5- and 6FAM-labelled) showed specific
amplification of An. arabiensis and An. quadriannulatus/An.
melas/An. merus respectively. However while the probe Ag
(VIC-labelled) also gave sensitive detection of An. gambiae
s.s., when An. quadriannulatus, An. melas or An. merus
DNAs were tested a low-level “background” fluorescence
signal was observed, presumably from nonspecific binding
of this probe. This could be eliminated by increasing the
annealing/extension temperature to 66◦C and lowering the
final probe concentration in the PCR from 200 to 80 nM.
However, when this assay was run on an alternative PCR
machine (Chromo4, Bio-Rad) using the modified conditions
and white PCR tubes, the same low-level “background” was
seen once more. Increasing the annealing/extension temper-
ature to 67◦C and lowering the final probe concentration in
the PCR from 200 to 50 nM showed a degree of improvement
but did not completely eliminate the background signal. In
practice, this background does not inhibit scoring as an An.
quadriannulatus, An. melas, or An. merus specimen shows
a strong signal in the Cy5 channel, while a true Anopheles
gambiae s.s. individual only shows signal in the VIC channel.
7.2. Specific Advice on the Plasmodium Detection Assay.
The Plasmodium detection assay was originally optimised
using genomic DNA templates, and carrying out 45
cycles of PCR. When tests were carried out on blood-fed
mosquitoes extracted by crude methods (such as boiling
whole mosquitoes in sucrose buﬀer), a small amount of
nonspecific fluorescence was sometimes seen after 40 cycles.
For this reason, we recommend restricting the number of
cycles in PCR to 40. In addition, we have had reports that the
Plasmodium assay is particularly sensitive to contamination
of reagents and so it is especially important to aliquot
reagents, to use filter sterilised water to make up reactions
and filter tips to dispense reaction components and DNA.
7.3. Specific Advice on the Detection of Knock down Resistance
(kdr) Assay. If separate runs have been performed on the
same samples for L1014F and L1014S, when interpreting the
results it is useful to have two copies of the real-time PCR
machine software open on the computer at once. In one copy
open the L1014F run and in the other open the L1014S run.
The same sample can then be viewed in each assay by moving
between the two runs/copies of the software. This helps to
rapidly assign each sample a genotype. Alternatively, if the
east and west assays were run together on the same samples,
the same approach can be followed using a single copy of the
software.
In our experience, distinguishing between L1014F
homozygous and heterozygous genotypes can seem less
obvious than scoring other genotypes because a L1014F
homozygous genotype shows a very low-level signal in the
VIC channel rather than a completely flat line (as with a
no-template control) (see Figure 2). In addition, the signal
strength from the FAM and VIC probes can be diﬀerent.
Running controls of the two genotypes is very helpful and
allows for a direct comparison with unknown samples.
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In our experiments, to date, when we have run the assay
on DNA extracted from a single leg, we have obtained mixed
results (possibly due to the low quality/concentration of
DNA extracted), and, therefore, we cannot recommend the
TaqMan kdr assays for this approach.
8. Summary and Future Development
Because the VPMT protocols developed to date are based
on a closed-tube approach, requiring a single step to achieve
results, they are simple, rapid to run, and high-throughput.
The results of the genotyping trials carried out in the
development of the various assays has also shown that the
platform on which they are based is robust, sensitive and
specific. The cost of each assay per mosquito analysed is
shown in Table 2 and is generally comparable, or in some
cases lower, than alternative methods. One disadvantage of
the TaqMan assay is the initial cost of the real-time PCR
machine required, which is in the region of US$ 19,000 to
25,000, compared to the startup cost of conventional PCR
of around US$ 10,000 [4]. Although the price of real-time
PCR machines is falling, and in the future is likely to become
comparable to standard thermocyclers, this may currently
represent an obstacle to full uptake of these protocols in
resource-poor malaria-endemic countries. Perhaps the most
significant limitation of the current VPMT is that, although
each individual assay is comparable or lower in cost than
alternatives, to screen an individual mosquito for every
single trait described in this paper is still expensive. We
are investigating the possibility of incorporating the current
VPMT assays into a single highly multiplexed platform that
would allow users to screen for all traits in a single test. A
possible platform that is a suitable candidate for such a role
is optical thin-film biosensors. Thin-film biosensor chips are
capable of transducing specific molecular interactions into
signals that can be visualized by the naked eye or by simple
digital-imaging systems because mass deposited on the thin-
film surface by enzymatic catalysis alters the wavelength of
light reflected by the optical layer resulting in a perceived
colour change on the surface [41]. The assay has been
described for SNP detection for several animal and plant
species and is reported to be robust, exhibit high sensitivity
and specificity, and is flexible from low to high throughput
[42–44]. We are currently examining the feasibility of using
this platform for a multiplexed version of the VPMT.
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